Free CME from PeerView


Urology CME

Pedro C. Barata, MD, MSc
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
November 30, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
November 30, 2021
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Changing Tides in Advanced Endometrial Cancer: A Visual Exploration of Current and Emerging Strategies to Maximize the Potential of Cancer Immunotherapies
November 29, 2021
Credits: 0.5 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
PrEP for All Ages: A Comprehensive Look at Employing HIV Prevention Strategies Across All Age Groups
November 17, 2021
Donna E. Sweet, MD, AAHIVS, MACP
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The HIV Prevention–Certified Provider Program: A Training and Certificate Program Designed to Improve Competencies and Expand the HIV Prevention Workforce
November 11, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
September 28, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
July 6, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
July 5, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
June 23, 2021
Credits: 0.50 CME / MOC
PVI, PeerView Institute for Medical Education
New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease
June 21, 2021
Credits: 1.00 CME / MOC / NCPD / ILNA
Medical Learning Institute, Inc.
The New Therapeutic Era in Renal Cell Carcinoma: Essentials for Team-Based Patient Care
May 17, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
May 11, 2021
Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
May 11, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
May 7, 2021
Credits: 1.00 CME / MOC
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
April 20, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
March 3, 2021
Penn State College of Medicine
How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape
July 8, 2020
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
June 22, 2020